Skip to content

Sotera Health SHC Cash & Equivalents

Cash & Equivalents at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$198.2M-14.5%
STERIS logo
STERISSTE
$439.6M+156%
Fortive logo
FortiveFTV
$356.1M-60.1%
Balchem logo
BalchemBCPC
$72.87M+46.0%
Natera, Inc. logo
Natera, Inc.NTRA
$1.09B+11.7%
Oklo logo
OkloOKLO
$15.57M+233%

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%
Enterprise value$6.47B+12.8%
P/E38.3×-109×
P/S3.8×+0.5×

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's cash & equivalents?
Sotera Health (SHC) reported cash & equivalents of $314.15M in Q1 2026.
How has Sotera Health's cash & equivalents changed year-over-year?
Sotera Health's cash & equivalents increased by 3.2% year-over-year, from $304.39M to $314.15M.
What is the long-term trend for Sotera Health's cash & equivalents?
Over 5 years (2020 to 2025), Sotera Health's cash & equivalents has grown at a 27.5% compound annual growth rate (CAGR), from $102.45M to $344.62M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.